Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain. (Q35680962)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 August 2011
edit
Language Label Description Also known as
English
Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain.
scientific article published on 11 August 2011

    Statements

    Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit